Recital 4, Regulation (EU) 2022/2182

In forcesince 30 Aug 2022

In its statement of 15 April 2021 on the additional scientific evidence in relation to the essential composition of total diet replacement for weight control [EFSA NDA Panel (EFSA Panel on Nutrition, Novel Foods and Food Allergens), 2021. Statement on additional scientific evidence in relation to the essential composition of total diet replacement for weight control. EFSA Journal 2021;19(4):6494.], the Authority concluded that there is no need to add linoleic acid to total diet replacement for weight control, as the amount released from the adipose tissue during weight loss when consuming total diet replacement for weight control is sufficient to cover the adequate intake for linoleic acid. The Authority further concluded that, while around 40 % of the adequate intake of alpha-linolenic acid could be provided by the release of alpha-linolenic acid from the adipose tissue during weight loss in overweight or obese individuals consuming total diet replacement for weight control, a minimum of 0,8 g/day needs to be supplied by total diet replacement for weight control in order to meet the adequate intake for alpha-linolenic acid. The Authority also concluded that an increase of the total maximum magnesium content in total diet replacement for weight control to 350 mg/day is not of concern. Even if magnesium may induce diarrhoea, the likelihood that magnesium-induced diarrhoea would occur as a result of such intake at a severity that may be considered of concern for overweight or obese individuals consuming total diet replacement for weight control is low, considering that those individuals more often suffer from constipation than diarrhoea.